D. Bousley

RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment

W. Zou, L. Carter, C. Lesch, 2019, Cancer Immunology Research.

Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity

P. Toogood, K. Majchrzak, G. Glick, 2016, Oncoimmunology.